| Predicting response to treatment in systemic sclerosis related interstitial lung disease in a multicenter observational cohort Involvement in Systemic Sclerosis |
Assassi |
Department of Defense |
| Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis |
Assassi/Wu |
NIH |
| Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis |
Assassi/Larin/Mohan |
NIH |
| CONQUER- Biorepository Coordinator Center |
Assassi |
SRF |
| Characterization of Somatic Mutations in Scleroderma |
Assassi |
SRF |
| Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Evaluate the Efficacy, Safety and Tolerability of Efzofitimod in Patients With Systemic Sclerosis Related Interstitial Lung Disease |
Assassi |
aTyr Pharma |
| Characterization of Factor XII (FXII) expression in SSc skin and fibroblasts |
Wu |
CSL Innovation Pty |
| Pathogenic effects of DNASE1L3 R206C polymorphism in systemic sclerosis |
Skaug |
NIH/RRF |
| The Relationship Between HLA-B27 Positivity and Inflammatory Back Pain in the US Population |
Hwang |
Spartan |